Equities
Health CareMedical Equipment and Services
  • Price (USD)63.43
  • Today's Change-1.19 / -1.84%
  • Shares traded935.72k
  • 1 Year change-17.99%
  • Beta0.4888
Data delayed at least 15 minutes, as of Jul 15 2025 20:51 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.

  • Revenue in USD (TTM)4.03bn
  • Net income in USD556.70m
  • Incorporated1990
  • Employees7.06k
  • Location
    Hologic Inc250 Campus DriveMARLBOROUGH 1752United StatesUSA
  • Phone+1 (508) 263-2900
  • Fax+1 (302) 655-5049
  • Websitehttps://www.hologic.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
HOLX:NSQ since
announced
Transaction
value
Gynesonics IncDeal completed14 Oct 202414 Oct 2024Deal completed-20.52%350.00m
Data delayed at least 15 minutes, as of Jul 15 2025 20:51 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Masimo Corp1.97bn-276.60m8.77bn3.60k--9.26--4.44-5.17-9.2136.5117.460.75172.426.30548,222.30-10.543.29-13.173.9950.5053.94-14.024.561.622.120.40750.002.2617.43-474.11---6.75--
Henry Schein Inc12.67bn407.00m8.84bn25.00k21.972.6112.680.69743.223.22100.1227.081.234.917.86506,760.003.885.436.389.1931.6030.233.163.980.75256.940.37990.002.714.88-6.25-11.0619.66--
Avantor Inc6.69bn715.60m9.01bn13.50k12.591.488.031.351.051.059.808.950.53295.696.01495,200.005.703.946.624.4833.5633.7610.706.870.75323.950.40240.00-2.642.35121.58--23.59--
Penumbra Inc1.24bn42.23m9.27bn4.50k233.287.63146.117.471.031.0331.3831.350.78161.026.89275,577.802.661.422.951.5866.3763.213.411.963.68--0.0190.0012.8616.89-84.59-21.98-0.853--
Revvity Inc2.77bn296.04m11.61bn11.00k40.661.5416.274.192.422.3522.7063.960.21483.054.59251,806.202.304.312.494.8456.2558.5010.6915.782.9914.590.29326.520.162-0.908657.704.201.274.56
Solventum Corp8.31bn379.00m12.82bn22.00k34.043.9313.881.542.182.1847.6918.850.56834.267.74377,636.402.59--3.05--54.71--4.55--0.85231.930.7081--0.6954---64.41------
Hologic Inc4.03bn556.70m14.40bn7.06k27.293.1216.873.582.372.3717.3120.730.46662.576.24570,083.606.4513.127.2715.2056.4460.8213.8324.752.52110.530.3540.00-0.00253.6673.14--4.30--
Align Technology Inc3.98bn409.56m14.45bn20.95k36.283.8425.763.635.495.4953.4151.940.64954.553.96190,061.706.6813.909.9420.5069.9271.2410.2920.951.08--0.000.003.5410.69-5.32-0.9865-5.04--
Baxter International Inc10.77bn-277.00m14.64bn38.00k--2.0720.771.36-0.5388-1.1021.0313.800.43882.645.04283,447.40-1.09-0.8441-1.37-1.0336.7338.63-2.49-2.031.403.650.5882--2.66-1.31-293.68---8.524.12
Cooper Companies Inc3.99bn414.20m14.69bn16.00k35.691.7718.883.682.062.0619.8641.540.32611.585.43249,262.503.398.723.689.7367.2065.7010.3926.351.236.800.23780.2828.417.9833.34-3.177.59--
Illumina Inc4.34bn-965.00m15.60bn8.97k--6.62--3.60-6.10-6.1027.2314.890.53472.606.36483,500.60-11.90-10.33-14.50-12.1566.3465.65-22.25-25.301.4817.300.4566---2.934.29-5.34---9.34--
West Pharmaceutical Services Inc2.90bn467.20m16.13bn10.60k35.276.0126.305.576.376.3739.4737.370.80214.635.30273,188.7012.5615.6115.0018.7034.5438.0015.6618.842.03--0.071610.20-1.929.48-16.9715.3124.435.84
Waters Corp2.98bn657.02m18.10bn7.60k27.619.2221.276.0711.0211.0250.0432.980.65562.314.45392,533.3014.4418.4118.0223.4659.2758.7122.0222.811.2813.770.4260.000.06674.22-0.68511.61-2.75--
Zimmer Biomet Holdings Inc7.70bn913.40m18.57bn17.00k20.801.509.642.414.514.5138.0662.630.35290.96225.17452,852.904.192.344.752.6871.0571.1811.887.601.466.460.366537.523.85-0.7725-11.742.05-3.690.00
Data as of Jul 15 2025. Currency figures normalised to Hologic Inc's reporting currency: US Dollar USD

Institutional shareholders

47.41%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 202525.77m11.48%
T. Rowe Price Investment Management, Inc.as of 30 Jun 202524.08m10.73%
BlackRock Fund Advisorsas of 31 Mar 202513.46m6.00%
SSgA Funds Management, Inc.as of 31 Mar 202510.11m4.51%
Morgan Stanley Investment Management Ltd.as of 31 Mar 20258.21m3.66%
Victory Capital Management, Inc. (Investment Management)as of 31 Mar 20256.61m2.95%
Geode Capital Management LLCas of 31 Mar 20255.73m2.55%
Invesco Capital Management LLCas of 31 Mar 20254.52m2.02%
Mitsubishi UFJ Asset Management Co., Ltd.as of 31 Mar 20254.47m1.99%
Columbia Management Investment Advisers LLCas of 31 Mar 20253.40m1.52%
More ▼
Data from 31 Mar 2025 - 31 Mar 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.